---
figid: PMC8379492__gr9
figtitle: 'Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK
  activation: In vitro and in vivo studies'
organisms:
- Armoracia rusticana
- Coriandrum sativum
- Vaccinium angustifolium
- Syzygium cumini
- Vaccinium ashei
- Mus musculus
- Rattus norvegicus
- Meriones shawi
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC8379492
filename: gr9.jpg
figlink: /pmc/articles/PMC8379492/figure/fig9/
number: F9
caption: Schematic of TLR4 signaling cascades. Blueberry anthocyanins (Mv, Mv-3-glc,
  Mv-3-gal, and BAE) regulated glucose and lipid metabolism by activation AMPK signal
  pathway. Activation of AMPK signal transduction through ROS inhibition leads to
  lower blood glucose and blood lipids (TG and TCH) through reducing glucogenesis
  (GS, G6Pase, PEPCK, PGC1α, and FOXO1), glucose transporter (GLUT2), and lipogenesis
  (ACC, HMGCR, and SREBP-1), as well as enhancing glycogenolysis (GSK3β) and lipolysis
  (HSL).
papertitle: 'Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK
  activation: In vitro and in vivo studies.'
reftext: Daniela D. Herrera-Balandrano, et al. Redox Biol. 2021 Oct;46:102100.
year: '2021'
doi: 10.1016/j.redox.2021.102100
journal_title: Redox Biology
journal_nlm_ta: Redox Biol
publisher_name: Elsevier
keywords: Anthocyanin | Blueberry | Diabetes | Hypoglycemic | Hypolipidemic | Malvidin
automl_pathway: 0.9391034
figid_alias: PMC8379492__F9
figtype: Figure
redirect_from: /figures/PMC8379492__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8379492__gr9.html
  '@type': Dataset
  description: Schematic of TLR4 signaling cascades. Blueberry anthocyanins (Mv, Mv-3-glc,
    Mv-3-gal, and BAE) regulated glucose and lipid metabolism by activation AMPK signal
    pathway. Activation of AMPK signal transduction through ROS inhibition leads to
    lower blood glucose and blood lipids (TG and TCH) through reducing glucogenesis
    (GS, G6Pase, PEPCK, PGC1α, and FOXO1), glucose transporter (GLUT2), and lipogenesis
    (ACC, HMGCR, and SREBP-1), as well as enhancing glycogenolysis (GSK3β) and lipolysis
    (HSL).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Slc2a2
  - Foxo1
  - Ppargc1a
  - oh
  - G6pc1
  - Pck1
  - gs
  - Gs
  - Hmgcr
  - Acc
  - Srebf1
  - Lipe
  - Tg
  - SLC2A2
  - FOXO1
  - PPARGC1A
  - G6PC1
  - G6PC2
  - G6PC3
  - PCK2
  - GNAS
  - GNAL
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - HMGCR
  - ACACA
  - BMS1
  - ACACB
  - SREBF1
  - LIPE
  - TG
  - Prkaa2
  - foxo
  - srl
  - G6P
  - Pepck2
  - Pepck1
  - SNF4Agamma
  - AMPKalpha
  - ACC
  - tacc
  - acclinal-wing
  - SREBP
  - hh
  - Hsl
---
